Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells
Alessandra Di Paola, Giuseppe Palumbo, Chiara Tortora, et al.
British Journal of Haematology (2021) Vol. 197, Iss. 1, pp. 110-119
Open Access | Times Cited: 19

Showing 19 citing articles:

Emerging Roles of the Iron Chelators in Inflammation
Alessandra Di Paola, Chiara Tortora, Maura Argenziano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7977-7977
Open Access | Times Cited: 51
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial
Yunfei Chen, Yanmei Xu, Ying Chi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Targeting ferroptosis: opportunities and challenges of mesenchymal stem cell therapy for type 1 diabetes mellitus
Le Dai, Qing Wang
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Novel perspective in transplantation therapy of mesenchymal stem cells: targeting the ferroptosis pathway
Yuzhu Xu, Fan Pan, Lei Liu, et al.
Journal of Zhejiang University SCIENCE B (2023) Vol. 24, Iss. 2, pp. 115-129
Open Access | Times Cited: 7
CB2 Receptor as Emerging Anti-Inflammatory Target in Duchenne Muscular Dystrophy
Maura Argenziano, Vincenzo Pota, Alessandra Di Paola, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3345-3345
Open Access | Times Cited: 7
Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics
Jennifer Gebetsberger, Werner Streif, Christof Dame
Hämostaseologie (2024) Vol. 44, Iss. 04, pp. 316-325
Open Access | Times Cited: 1
Interplay of leucocyte–platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients
Rubén Osuna‐Gómez, Carlos Zamora, Silvana Novelli, et al.
British Journal of Haematology (2024)
Closed Access | Times Cited: 1
Effect of Calcitriol Treated Mesenchymal Stem Cells as an Immunomodulation Micro-environment on Allergic Asthma in a Mouse Model
Majdedin Ghalavand, Hadi Esmaeili Gouvarchin Ghaleh, Mostafa Khafaei, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 23, Iss. 8, pp. 1096-1103
Closed Access | Times Cited: 4
Efficacy and Immunomodulating Properties of Eltrombopag in Aplastic Anemia following Autologous Stem Cell Transplant: Case Report and Review of the Literature
Marta Bortolotti, Loredana Pettine, Anna Zaninoni, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 419-419
Open Access | Times Cited: 6
Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells
Sandra Muntión, Silvia Preciado, Elena Sánchez-Luis, et al.
Therapeutic Advances in Hematology (2022) Vol. 13
Open Access | Times Cited: 4
Progress in the Treatment of Eltrombopag for Adult Primary Immune Thrombocytopenia
赖林 李
Advances in Clinical Medicine (2024) Vol. 14, Iss. 02, pp. 3004-3010
Closed Access
Activation of the HMGB1‐TLR4 pathway impacts the functionality of bone marrow mesenchymal stem cells and disrupts macrophage polarization in immune thrombocytopenia
Ziyang Liang, Guoyang Zhang, Guangting Gan, et al.
British Journal of Haematology (2024)
Closed Access
Eltrombopag restores proliferative capacity and adipose-osteogenic balance of mesenchymal stromal cells in low-risk myelodysplastic syndromes.
Minghua Hong, Juan Guo, Youshan Zhao, et al.
European Journal of Pharmacology (2024), pp. 177086-177086
Closed Access
The long-term efficacy of eltrombopag in children with immune thrombocytopenia
Yang Li, Bao-Hua Sang, Chunhui Yang, et al.
Research Square (Research Square) (2024)
Open Access
The long-term efficacy of eltrombopag in children with immune thrombocytopenia
Li- Yang, Bao-Hua Sang, Chunhui Yang, et al.
Annals of Hematology (2024) Vol. 103, Iss. 8, pp. 2721-2727
Closed Access
Early immunomodulation in immune thrombocytopenia—A report of the ICIS meeting in Lenzerheide, Switzerland 2022
Tomás José González‐López, Alexandra Schifferli
British Journal of Haematology (2023) Vol. 203, Iss. 1, pp. 101-111
Open Access | Times Cited: 1
Abstracts of the 41st SIF National Congress
AA.VV. AA.VV.
(2023), Iss. Supplement, pp. 07-07
Open Access
Effects of eltrombopag on mesenchymal stem cells in immune thrombocytopenia purpura
Britta Will
British Journal of Haematology (2022) Vol. 197, Iss. 2, pp. 137-138
Closed Access
Page 1

Scroll to top